Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine

被引：0
作者：
Jing Jin
Feng-Peng Wang
Huailing Wei
Gengtao Liu
机构：
[1] University of Cambridge,Department of Pharmacology
[2] Sichuan University,Department of Medicinal Natural Products, West China College of Pharmacy
[3] Chinese Academy of Medical Sciences,Department of Pharmacology, Institute of Materia Medica
[4] Peking Union Medical College and Chinese Academy of Medical Sciences,Department of Pharmacology, Institute of Materia Medica
来源：
Cancer Chemotherapy and Pharmacology | 2005年 / 55卷
关键词：
Multidrug resistance; Modulator; Bromotetrandrine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：179 / 188
页数：9
相关论文
共 50 条
  • [31] Reversal of P-glycoprotein and multidrug resistance-associated protein 1 mediated multidrug resistance in cancer cells by HZ08 isomers, tetrataisohydroquinolin derivatives
    Yan, Fang
    Jiang, Yi
    Li, Yun-Man
    Zhen, Xia
    Cen, Juan
    Fang, Wei-Rong
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (06) : 1258 - 1264
  • [32] Flavonoids as P-glycoprotein inhibitors for multidrug resistance in cancer: an in-silico approach
    Kumar, Amit
    Kalra, Sourav
    Jangid, Kailash
    Jaitak, Vikas
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (16) : 7627 - 7639
  • [33] The molecular basis of multidrug resistance in cancer: The early years of P-glycoprotein research
    Gottesman, MM
    Ling, V
    FEBS LETTERS, 2006, 580 (04) : 998 - 1009
  • [34] Novel application of rhein and its prodrug diacerein for reversing cancer-related multidrug resistance through the dual inhibition of P-glycoprotein efflux and STAT3-mediated P-glycoprotein expression
    Teng, Yu-Ning
    Kao, Ming-Chang
    Huang, Shih-Ya
    Wu, Tian-Shung
    Lee, Tsui-Er
    Kuo, Chan-Yen
    Hung, Chin-Chuan
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 150
  • [35] Enabling P-glycoprotein inhibition in multidrug resistant cancer through the reverse targeting of a quinidine-PEG conjugate
    Snyder, Sarah
    Murundi, Shamanth
    Crawford, Lindsey
    Putnam, David
    JOURNAL OF CONTROLLED RELEASE, 2020, 317 : 291 - 299
  • [36] Effects of celecoxib on the reversal of multidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P-glycoprotein
    Huang, Libin
    Wang, Chunhui
    Zheng, Wenbin
    Liu, Rui
    Yang, Jinfin
    Tang, Chengwei
    ANTI-CANCER DRUGS, 2007, 18 (09) : 1075 - 1080
  • [37] Association between reversal of multidrug resistance by methyl jasmonate and P-glycoprotein ATPase activity in hepatocellular carcinoma
    Wang, Chang-Fa
    Wang, Ya-Qin
    Huang, Fei-Zhou
    Nie, Wan-Pin
    Liu, Xun-Yang
    Jiang, Xian-Zhen
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2013, 41 (04) : 964 - 974
  • [38] Wilforine resensitizes multidrug resistant cancer cells via competitive inhibition of P-glycoprotein
    Chang, Ying-Tzu
    Lin, Yu-Chao
    Sun, Lijuan
    Liao, Wei-Chieh
    Wang, Charles C. N.
    Chou, Che-Yi
    Morris-Natschke, Susan L.
    Lee, Kuo-Hsiung
    Hung, Chin-Chuan
    PHYTOMEDICINE, 2020, 71
  • [39] The P-glycoprotein multidrug transporter
    Fardel, O
    Lecureur, V
    Guillouzo, A
    GENERAL PHARMACOLOGY, 1996, 27 (08): : 1283 - 1291
  • [40] The mechanism of action of multidrug-resistance-linked P-glycoprotein
    Sauna, ZE
    Smith, MM
    Müller, M
    Kerr, KM
    Ambudkar, SV
    JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2001, 33 (06) : 481 - 491
12345